The Race to Develop the Pfizer-BioNTech COVID-19 Vaccine: From the Pharmaceutical Scientists’ Perspective

por Lewis, Lavinia M, Badkar, Advait V, Cirelli, David, Combs, Rodney, Lerch, Thomas F
Publicado 2023

Crystal structures of wild-type and mutated cyclophilin B that causes hyperelastosis cutis in the American quarter horse

por Boudko, Sergei P, Ishikawa, Yoshihiro, Lerch, Thomas F, Nix, Jay, Chapman, Michael S, Bächinger, Hans Peter
Publicado 2012

Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar

por Lerch, Thomas F., Sharpe, Penelope, Mayclin, Stephen J., Edwards, Thomas E., Polleck, Sharon, Rouse, Jason C., Zou, Qin, Conlon, Hugh D.
Publicado 2019

Oligonucleotide mapping via mass spectrometry to enable comprehensive primary structure characterization of an mRNA vaccine against SARS-CoV-2

por Gau, Brian C., Dawdy, Andrew W., Wang, Hanliu Leah, Bare, Bradley, Castaneda, Carlos H., Friese, Olga V., Thompson, Matthew S., Lerch, Thomas F., Cirelli, David J., Rouse, Jason C.
Publicado 2023

Characterization of BNT162b2 mRNA to Evaluate Risk of Off-Target Antigen Translation

por Patel, Himakshi K., Zhang, Kun, Utegg, Rachael, Stephens, Elaine, Salem, Shauna, Welch, Heidi, Grobe, Svenja, Schlereth, Julia, Kuhn, Andreas N., Ryczek, Jeff, Cirelli, David J., Lerch, Thomas F.
Publicado 2023